Iterum TherapeuticsITRMF
13F holders, Q2 2024 (June 30)14holders −2
3new positions
5sold out
1famous investor
$1.15avg. 13F price*
At the end of Q2 2024, 14 institutions reported holding Iterum Therapeutics PLC (ITRMF) in their 13F filings, down 2 from Q1 2024. 3 opened new positions and 5 sold out. The largest holders were Apollon Financial, LLC ($257K), New Leaf Venture Partners, L.L.C. ($111K) and Renaissance Technologies ($73K). One famous investor held it Jim Simons / Peter Brown (0.0% of Renaissance Technologies's portfolio).
- Company
- Iterum Therapeutics PLC
- CUSIP
- G6333L200
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q1 2024 → Q2 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 3 | $45K |
| Exits | 5 | $735K |
All 13F filers, Q1 2024 → Q2 2024: 38,658 shares bought and 535,846 shares sold, net −497,188 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 14 holders
| Apollon Financial, LLC | 0.08% | No change | 224,750 | $257K |
| New Leaf Venture Partners, L.L.C. | 0.14% | Add +0.0% | 97,086 | $111K |
| Renaissance Technologies | 0.00% | Reduce -42.0% | 64,022 | $73K |
| Susquehanna International Group, LLP | 0.00% | New | 38,483 | $45K |
| Morgan Stanley | 0.00% | No change | 5,479 | $6K |
| Wells Fargo & Company | 0.00% | No change | 1,285 | $1K |
| Activest Wealth Management | 0.00% | New | 133 | $152 |
| Kelly Financial Services LLC | 0.00% | No change | 120 | $137 |
| Tower Research Capital LLC (TRC) | 0.00% | Reduce -78.6% | 100 | $114 |
| Planning Capital Management Corp | 0.00% | New | 40 | $46 |
| Osaic Holdings, Inc. | 0.00% | No change | 12 | $13 |
| HM Payson & Co. | 0.00% | No change | 3 | $4 |
| National Bank of Canada | 0.00% | No change | 2 | $2 |
| UBS Group AG | 0.00% | Reduce -100.0% | 1 | $1 |
"% of holder's portfolio" is ITRMF's weight in each manager's 13F, not the share of Iterum Therapeutics PLC the manager owns.